(Q53808927)

20 May 2018

title

Controlled trials of phenobarbitone therapy of neonatal jaundice. (English)

1 reference

20 May 2018

author name string

C Ramboer

series ordinal

1

1 reference

20 May 2018

R P Thompson

series ordinal

2

1 reference

20 May 2018

R Williams

series ordinal

3

1 reference

20 May 2018

language of work or name

English

0 references

publication date

1 May 1969

1 reference

20 May 2018

published in

The Lancet

1 reference

20 May 2018

volume

1

1 reference

20 May 2018

issue

7602

1 reference

20 May 2018

page(s)

966-968

1 reference

20 May 2018

Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months. A preliminary report from the collaborative project

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Barbiturate Enhancement of Bilirubin Conjugation and Excretion in Young and Adult Animals[35]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

ALTERATIONS IN SULFOBROMOPHTHALEIN SODIUM-REMOVAL MECHANISMS FROM BLOOD DURING NORMAL PREGNANCY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Clinical experience with phenobarbitone in icterus neonatorum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Reduction in concentration of total serum-bilirubin in offspring of women treated with phenobarbitone during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Physiologic Hyperbilirubinemia in the Neonatal Period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Effect of phenobarbitone on low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Low plasma-bilirubin in epileptics on phenobarbitone.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

A possible drop in first-week-mortality rate for low-birth-weight infants after phenobarbitone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Barbiturate and hyperbilirubinaemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

Increase in levels of glucuronylating enzymes and associated rise in activities of mitochondrial oxidative enzymes upon phenobarbital administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2869%2991862-5

7 January 2021

10.1016/S0140-6736(69)91862-5

Identifiers

DOI

1 reference

20 May 2018

PubMed ID

4180816

1 reference

20 May 2018